David Ege

David Ege serves as EVP Bioprocess & Manufacturing; Chief Technology Officer at Seres Therapeutics. Seres Therapeutics operates in the research sector with approximately 190.0 employees. The company is headquartered in New York, New York. Seres Therapeutics generates annual revenue of 126325000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Seres Therapeutics.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Gmail Outlook Google Apps Microsoft Office 365 Greenhouse.io Google Cloud Hosting ON24 Mobile Friendly reCAPTCHA Google Maps (Non Paid Users) Typekit Nginx New Relic Google Analytics WordPress.org Google Maps Google Tag Manager AI Remote

biotechnology therapeutics microbiome biotechnology: pharmaceutical preparations health care biotechnology research microbiome therapeutics clostridioides difficile antimicrobial resistance graft-versus-host disease fda approval ser-109 ser-155 immune modulation cancer immunotherapy ulcerative colitis gastrointestinal infections clinical trials drug development preclinical studies commercialization healthcare professionals patient outcomes infectious diseases fecal microbiota transplantation therapeutic pipeline biologics manufacturing precision medicine microbial physiology bioinformatics regulatory approval immunosuppression therapies antibiotics safety & efficacy therapeutic products biotechnology finance microbial ecology public health clinical development personalized medicine public-private partnerships healthcare marketing investor relations marketing strategy clinical pharmacology translational medicine biotechnology trends scientific advisory microbiome modulation complementary therapies live biotherapeutics clostridium difficile infection gastrointestinal diseases immune-mediated conditions ser-262 patient-centric innovative therapies gastroenterologists infectious disease specialists patient advocacy pharmaceutical partnerships clinical-stage development breakthrough therapy oral delivery microbiome science health-conscious individuals transformative treatments disease prevention bacterial consortia scientific research advanced manufacturing healthcare innovation serious diseases medical vulnerability therapeutic efficacy microbiome ecology health solutions health wellness & fitness hospital & health care information technology & services marketing & advertising

ES

Eric Shaff President, Chief Executive Officer at Seres Therapeutics

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like David Ege in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Seres Therapeutics.

David Ege's Position in the MessageCEO Database

• •David Ege is 1 of 2 verified executive contacts we track at Seres Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •6,778 verified executive contacts in New York are in the database.
• •39 verified contacts work at research companies in the 190.0 employee range (same size as Seres Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach David Ege directly?

David Ege's verified email address is available to MessageCEO Pro subscribers. They currently serve as EVP Bioprocess & Manufacturing; Chief Technology Officer at Seres Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does David Ege work for?

David Ege is EVP Bioprocess & Manufacturing; Chief Technology Officer at Seres Therapeutics, a company in the research sector with 190.0 employees. The company is based in New York, New York.

Can I pitch or sell to David Ege?

As EVP Bioprocess & Manufacturing; Chief Technology Officer at Seres Therapeutics, David Ege is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach David Ege directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is David Ege in?

David Ege works in the research industry as EVP Bioprocess & Manufacturing; Chief Technology Officer at Seres Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is David Ege's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. David Ege's profile is kept up-to-date with the latest available information.

Last updated: July 13, 2026